UPL Limited — PPTs, 31-01-2025: Investor Presentation

**Financial Highlights:** UPL reported a robust Q3 performance with revenue reaching ₹10,907 Cr, up 10% year-on-year, driven by a 9% volume increase and positive pricing. The EBITDA surged to ₹2,163 Cr, reflecting a remarkable 420% growth with a margin of 19.8%, up 1,560 bps. Notably, contribution profit showed a significant increase of 66% to ₹4,476 Cr.

**Strategic Initiatives and Growth Drivers:** The company emphasizes volume growth primarily from Latin America and Europe, particularly in fungicides and insecticides. Continued improvement in product mix and cost efficiencies supported margin accretion.

**Business Developments:** UPL's recent transaction with Alpha Wave Global involves a US$ 350 million investment for a 12.44% stake in Advanta Enterprises Limited, aimed at expediting growth initiatives and balancing UPL's finances.

**Market Position and Competitive Advantage:** With strong performance in key markets and improved cash management, UPL is well-positioned to navigate challenges, leveraging robust demand in its product segments.

**Investor Implications:** Given the substantial growth in both revenue and EBITDA, coupled with strategic capital initiatives, UPL appears to have a positive outlook, presenting potential growth opportunities for investors.